Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children

International Journal of Pediatric Otorhinolaryngology

Volumn 69, Issue 9, 2005, Pages 1225-1233

  Casellas Jr , Javier María ^a,b   Israele, Víctor ^a   Marín, Marcelo ^b   Ishida, María T ^a   Heguilen, Ricardo ^c   Soutric, Jorge ^c   Arenoso, Héctor ^c   Sibbald, Andrés ^d   Stamboulian, Daniel ^b  

^a Hospital de San Isidro   (Argentina)

^b Fundacion Centro de Estudios Infectologicos   (Argentina)

^c Laboratorios Bago   (Argentina)

^d HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Acute otitis media; Amoxicillin clavulanic acid; Amoxicillin sulbactam; Children

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMOXICILLIN PLUS SULBACTAM; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CLAVULOX DUO; TRIFAMOX IBL DUO; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARGENTINA; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NOSE SMEAR; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ACUTE DISEASE; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ARGENTINA; CARRIER STATE; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STREPTOCOCCUS PNEUMONIAE; SULBACTAM; TREATMENT OUTCOME;

EID: 23244451598     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2005.03.016     Document Type: Conference Paper

References (35)

1. D.W. Steele, J.O. Klein, B. Rosner Greater Boston Otitis Media Study Group Epidemiology of otitis media during seven years of life in children in greater Boston a prospective, cohort study for children with persisting middle ear effusions Pediatrics 93 1994 353 356
2. S.S. Long, F.M. Henretig, M.J. Teter, and K.L. Mc Gowen Nasopharyngeal flora and acute otitis media Infect. Immun. 41 1983 987 991
3. P. Marchisio, S. Esposito, G.C. Schito, A. Marchese, R. Cavagna, N. Principi and the Hercules Project Collaborative Group Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine Emerg. Infect. Dis. 8 5 2002 479 484
4. E.D.G. McIntosh, and R. Booy Invasive pneumococcal disease in England and Wales: what is the burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine Arch. Dis. Child 86 2002 403 406
5. M.M. Davis, S.M. Ndiaye, G.L. Freed, and S.J. Clark One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians J. Am. Board Fam. Pract. 16 2003 363 371
6. M. Eldan, E. Leibovitz, and L. Piglansky Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children Pediatr. Infect. Dis. J. 19 2000 298 303
7. S.Z. Doktor, J. Beyer, P. Johnson, M. Paris, R. Flamm, and D. Shortridge Characterization of haemophilus influenzae in pediatric otitis patients: a comparison of flora from nasooroppharyngyl cultures vs. those in middle ear fluid Proceedings of the 43rd ICAAC Chicago, USA, 14-17 September 2003 ICAAC abstracts: abstract number G-1851
8. K.L. O'Brien, H. Nohynek and the WHO Pneumococcal Vaccine Trials Carriage Working Group Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae Pediatr. Infect. Dis. J. 22 2003 133 141
9. R. Dagan, and G.H. McCracken Jr. Flaws in design and conduct of clinical trials in acute otitis media Pediatr. Infect. Dis. 21 2002 894 902
10. S.F. Dowell, J.C. Butler, and G.S. Giebink Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group Pediatr. Infect. Dis. J. 18 1999 1 9
11. R. Dagan, R. Melamed, M. Muallem, and P. Yagupsky Nasopharyngeal colonization in southern israel with antibiotic resistant Pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines J. Infect. Dis. 174 1996 1352 1355
12. S.L. Block, C.J. Harrison, and J.A. Hedrick Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management Pediatr. Infect. Dis. J. 14 1995 751 759
13. American Academy of Pediatrics and American Academy of Family Physician, Clinical Practice Guideline, Subcommittee on Managenement of Acute Otitis Media, Diagnosis and Management of Acute Otitis Media, Pediatrics 113 (2004) 1451-65.
14. R.F. Jacobs Judicious use of antibiotics for common pediatric respiratory infections Pediatr. Infect. Dis. J. 19 2000 938 943
15. C. Bantar, F. Nicola, and L. Fernandez Canigia A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections J. Chemother. 12 2000 223 227
16. Guidance for industry, Acute otitis media - developing antimicrobial drugs for treatment, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 21 July 1998 (available at www.fda.gov/cder/guidance/index.htm ).
17. D. Lehmann, M. Gratten, and J. Montgomery Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive Pneumococci Pediatr. Infect. Dis. J. 16 1997 297 305
18. J. Montgomery, D. Lehmann, and T. Smith Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in highland children of Papua New Guinea Rev. Infect. Dis. 12 Suppl. 8 1990 s1006 s1016
19. J.M. Casellas Jr., M.C. Espínola, S. Spinolla, et al., Nasal carriage of oxacillin-resistant (OR) Streptococcus pneumoniae (Spn) in children from five health centers from Paraguay. Presented at 38th IDSA, New Orleans, LA, 7-10 September 2000 (Abstract #93).
20. NCCLS, Performance standards for antimicrobial testing, 12th informational supplement. NCCLS document M100-S12, Wayne, PA, NCCLS, 2002.
21. J.M. Casellas Sr., H.J. Arenoso, and J.L. Soutric Estudio comparativo in vitro e in vivo de tres asociaciones de inhibidores suicidas de β-lactamasas con aminopenicilinas Rev. Esp. Quimioter. 6 4 1993 289 297
22. B. Jones, P. Jarvis, J.A. Lewis, and A.F. Ebbutt Trials to assess equivalence: the importance of rigorous methods Br. Med. J. 313 1996 36 39
23. R. Dagan, A. Hoberman, C. Johnston, E.L. Leibovitz, A. Arguedas, F.V. Rose, B.R. Wynne, and M.R. Jacobs Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media Pediatr. Infect. Dis. J. 20 9 2001 829 837
24. H. Dabernat, P. Geslin, and F. Meglaud Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media J. Antimicrob. Chemother. 41 1998 253 258
25. L. Piglansky, E. Libowitz, and S. Raiz Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children Pediatr. Infect. Dis. J. 22 2003 405 412
26. B. Jones, P. Jarvis, J.A. Lewis, and A.F. Ebbutt Trials to assess equivalence: the importance of rigorous methods Br. Med. J. 313 1996 36 39
27. P. O'Neill Acute otitis media Br. Med. J. 319 1999 833 835
28. V. Howie Erradication of bacterial pathogens from middle ear infections Clin. Infect. Dis. 14 Suppl. 1992 s209 s211
29. J.O. Klein Microbiologic efficacy of antibacterial drugs for acute otitis media Pediatr. Infect. Dis. J. 12 1993 973 975
30. S.A. Carlin, C.D. Marchant, P.A. Shirin, C.E. Johnson, D.M. Siper, and J.M. Rehmus Host factors and early therapeutic response in acute otitis media J. Pediatr. 18 1991 178 183
31. R. Dagan, E. Leibovitz, D. Grinberg, P. Yagupsky, D.M. Fliss, and A. Leiberman Early erradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome Pediatr. Infect. Dis. J. 17 1998 776 782
32. K.H. Chan, C.D. Bluestone, and L.S. Tan Comparative study of sultamycilin and amoxicillinclavulanate: treatment of acute otitis media Pediatr. Infect. Dis. J. 12 1993 24 28
33. A. Hoberman, J.L. Paradise, S. Block, D.J. Burch, M.R. Jacobs, and M.I. Balanescu Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility Pediatr. Infect. Dis. J. 15 1996 955 962
34. R. Dagan, C.E. Johnston, S. McLinn, N. Abughali, J. Feris, E. Leibovitz, D.J. Burch, and M.R. Jacobs Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media Pediatr. Infect. Dis. J. 2 2000 95 104
35. J.D. Barlett Antibiotic-associated diarhea N. Engl. J. Med. 346 2002 334 339